Home
>
National Drug Code (NDC)
>
cisatracurium besylate
cisatracurium besylate - 0781-3152-95 - (cisatracurium besylate)
Drug Information of cisatracurium besylate
| Product NDC: | 0781-3152 |
| Proprietary Name: | cisatracurium besylate |
| Non Proprietary Name: | cisatracurium besylate |
| Active Ingredient(s): | 2 mg/mL & nbsp; cisatracurium besylate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of cisatracurium besylate
| Product NDC: | 0781-3152 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200159 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120716 |
Package Information of cisatracurium besylate
| Package NDC: | 0781-3152-95 |
| Package Description: | 10 VIAL, MULTI-DOSE in 1 CARTON (0781-3152-95) > 10 mL in 1 VIAL, MULTI-DOSE (0781-3152-70) |
NDC Information of cisatracurium besylate
| NDC Code | 0781-3152-95 |
| Proprietary Name | cisatracurium besylate |
| Package Description | 10 VIAL, MULTI-DOSE in 1 CARTON (0781-3152-95) > 10 mL in 1 VIAL, MULTI-DOSE (0781-3152-70) |
| Product NDC | 0781-3152 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cisatracurium besylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120716 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | CISATRACURIUM BESYLATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
